BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36409003)

  • 1. Validation of an administrative coding algorithm for the identification of individuals with amyloid light chain amyloidosis using administrative data.
    Jimenez-Zepeda VH; Reece D; Rigo R; Gogna P; Kong S; Hu XY; Chapani P; Cheung WY; Brenner DR; Plante R; Shi K; Husain A; Ammann E; Tankala D; Boyne DJ
    Leuk Lymphoma; 2023 Jan; 64(1):256-258. PubMed ID: 36409003
    [No Abstract]   [Full Text] [Related]  

  • 2. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
    Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
    BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucocutaneous Xanthodermatosis as Initial Presentation of Immunoglobulin Light Chain Amyloidosis.
    da Fonseca AM; Furlan BB; Irffi GP; de Oliveira GB; Souza EG; Rezende SM
    Am J Med; 2022 Jun; 135(6):724-727. PubMed ID: 35081385
    [No Abstract]   [Full Text] [Related]  

  • 4. Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis.
    Ravichandran S; Law S; Mahmood S; Wisniowski B; Foard D; Fontana M; Martinez-Naharro A; Whelan C; Gillmore JD; Lachmann HJ; Hawkins PN; Wechalekar AD
    Leukemia; 2022 Apr; 36(4):1180-1184. PubMed ID: 34987193
    [No Abstract]   [Full Text] [Related]  

  • 5. A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis.
    Ravichandran S; Mahmood S; Wisniowski B; Sachchithanantham S; Popat R; Lachmann H; Rabin N; Ramasamy K; Hawkins S; Kyriakou C; Gillmore J; Yong K; Hawkins P; Jackson G; Pratt G; D Wechalekar A
    Br J Haematol; 2022 Jul; 198(2):328-332. PubMed ID: 35509237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoral hemorrhagic bullae as the first sign of immunoglobulin light chain amyloidosis.
    Dominguez-Lopez RM; Naharro-Rodriguez J
    CMAJ; 2024 May; 196(20):E705. PubMed ID: 38802132
    [No Abstract]   [Full Text] [Related]  

  • 7. Localized amyloidogenic immunoglobulin light chain-derived amyloidosis in a young boy and an adolescent girl.
    Ikeda SI
    Amyloid; 2017 Jun; 24(2):138-140. PubMed ID: 28632454
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra- and extracellular crystal deposition in a case of amyloid light chain amyloidosis.
    Mullen CG; Clarke SE; Doig T; Campbell VL
    Br J Haematol; 2022 Feb; 196(3):463. PubMed ID: 34775596
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic Amyloidosis Due to Clonal Plasma Cell Diseases.
    Bianchi G; Kumar S
    Hematol Oncol Clin North Am; 2020 Dec; 34(6):1009-1026. PubMed ID: 33099420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
    Chyra Z; Sevcikova T; Vojta P; Puterova J; Brozova L; Growkova K; Filipova J; Zatopkova M; Grosicki S; Barchnicka A; Jedrzejczak WW; Waszczuk-Gajda A; Jungova A; Mikulasova A; Hajduch M; Mokrejs M; Pour L; Stork M; Harvanova L; Mistrik M; Mikala G; Robak P; Czyz A; Debski J; Usnarska-Zubkiewicz L; Jurczyszyn A; Stejskal L; Morgan G; Kryukov F; Budinska E; Simicek M; Jelinek T; Hrdinka M; Hajek R
    Haematologica; 2021 Feb; 106(2):601-604. PubMed ID: 32381580
    [No Abstract]   [Full Text] [Related]  

  • 11. [AL amyloidosis, from diagnosis to treatment].
    Villesuzanne C; Jaccard A; Nicol M
    Rev Prat; 2020 Dec; 70(10):1137-1141. PubMed ID: 33739663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in understanding and treating immunoglobulin light chain amyloidosis.
    Badar T; D'Souza A; Hari P
    F1000Res; 2018; 7():. PubMed ID: 30228867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of systemic light chain AL amyloidosis.
    Bhutani D; Lentzsch S
    Pharmacol Ther; 2020 Oct; 214():107612. PubMed ID: 32562825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis.
    Heybeli C; Bentall A; Wen J; Alexander MP; Buadi FK; Cosio FG; Dean PG; Dispenzieri A; Dingli D; El Ters M; Gertz MA; Hatem A; Kapoor P; Khamash H; Kourelis T; Kumar S; Lorenz EC; Mai M; Muchtar E; Murray DL; Prieto M; Schinstock CA; Stegall MD; Warsame R; Leung N
    Kidney Int; 2021 Mar; 99(3):707-715. PubMed ID: 32712168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis.
    Sidana S; Dasari S; Kourelis TV; Dispenzieri A; Murray DL; King RL; McPhail ED; Ramirez-Alvarado M; Kumar SK; Gertz MA
    Blood Adv; 2021 Apr; 5(8):2101-2105. PubMed ID: 33877297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AL amyloidosis diagnosed using anti-IGLL5 antibody: a case report.
    Hiroi T; Mushino T; Tanaka K; Furuya Y; Hori Y; Oiwa T; Kobata H; Yamashita Y; Hosoi H; Murata S; Nishikawa A; Tamura S; Takeuchi S; Nohgawa M; Yamashita T; Ando Y; Hata H; Sonoki T
    Amyloid; 2019; 26(sup1):111-112. PubMed ID: 31343322
    [No Abstract]   [Full Text] [Related]  

  • 18. A first report of endoscopic ultrasound for the diagnosis of pancreatic amyloid deposition in immunoglobulin light chain (AL) amyloidosis (primary amyloidosis).
    Krishna SG; Bhutani MS; Mosher CH; Staerkel GA; Weston BR
    JOP; 2013 May; 14(3):283-5. PubMed ID: 23669481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
    Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
    Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis.
    Sharpley FA; Manwani R; Mahmood S; Sachchithanantham S; Lachmann HJ; Gillmore JD; Whelan CJ; Fontana M; Hawkins PN; Wechalekar AD
    Blood Cancer J; 2019 Feb; 9(2):16. PubMed ID: 30718462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.